Stronger sense of security thanks to digital follow-up of oncology patients at home

27 April 2018

Digital follow-up at home receives Health & Care Award

The mobile health project AMTRA digitally monitors oncology patients at home via their smartphones. 82% of the patients feel more secure thanks to the continuous monitoring of their symptoms and vital parameters. On April 25th 2018, AMTRA received the jury and public award during the health-care exhibition Health & Care at Expo Ghent.

E-health quickly gains ground in the field of medicine. As part of minister Maggie De Block’s mobile health pilot projects, the pilot project AMTRA (Ambulant Monitoring of Cancer Therapy using a smaRtphone Application) ran for twelve months (July 2017 – June 2018) in four oncology centers: Antwerp University Hospital, AZ Maria Middelares Gent, Grand Hôpital de Charleroi and CHU UCL Namur. It was examined to what extent oncology patients can be followed digitally at home via their smartphones.

Monitoring vital parameters and medication intake

The AMTRA app is used by cancer patients who are administered oral or intravenous chemo-, immune- or targeted therapy. Patients download the app to their smartphones and receive scales and/or a blood pressure monitor to take home with them. The application notifies the patients at regular points in time, to ensure they correctly take their medication and pass on vital parameters such as weight, blood pressure and heart rate to the doctors involved. Patients can also indicate side effects and how serious those are, so they can be treated faster.

First results

After a trial period of 12 months with 184 oncology patients, the first results are known. 82% of the patients feel safer because of the constant monitoring of vital parameters. 80% of the patients say that contact with health-care providers improves by means of using the app. The parameters added by the patients are automatically sent to a secured environment to which only the people involved have access: the patient, the doctor and the oncology nurses. In 52% of the cases, that results in the gaining of time during well-prepared consultations. 71% of the participants would recommend the app to fellow sufferers. In total, 90% of the patients who used AMTRA indicated that they are pleased with the application.

Closer, customized follow-up

Because of the doctors’ and nurses’ constant feedback via the smartphone application among others, the patient is more aware of how he or she treats his or her body and more meticulously takes home medication. The patient immediately indicates the chemo treatment’s side effects via the app, so possible complications can be treated more quickly. Because of that, patients are able to maintain medication with the optimal dosage longer and with fewer interruptions. Prof Dr Marc Peeters, head of department of oncology at Antwerp University Hospital (UZA), explains: “The ideal chemo dosage is determined per person. The treatment runs optimally when the antitumor medication is administered in accordance with that ideal dosage schedule. The AMTRA project has shown that interaction with patients improves and as a result, they can be administered their medication with fewer interruptions or dosage reductions. Thanks to that, the patients’ chances of survival increase.”

Digital follow-up at home receives Health & Care Award

On April 25th 2018, AMTRA received the jury and public award during the health-care exhibition Health & Care at Expo Ghent. A jury nominated three projects, after which they as well as the public chose a winner. The two awards are a reward for the unique collaboration between hospitals, patients and the industry. In 2017, AMTRA already placed first for the ‘Zorgvinding’ award in the category ‘cancer care’.

Project partners

  • Antwerp University Hospital (UZA)
  • AZ Maria Middelares Ghent
  • Grand Hôpital de Charleroi
  • CHU UCL Namur
  • Remedus

Share

Recent news

Read our latest news

Remecare-App validated as medical trusted app

Global

01 May 2019

Remecare-App validated as medical trusted app

After years of development work and medical trials, Remedus is proud to announce that its RemeCare mobile health app has…

Read more
Medical Need Programs

Global, Pharma Services

15 December 2018

Medical Need Programs

Remedus offers a platform to digitalize the entire Medical Need Program or compassionate use program workflow. Remedus is ISO13485 certified,…

Read more
Generating Real-World Data

Global, Pharma Services

14 December 2018

Generating Real-World Data

RWE typically consists of many types of Real-World Data (RWD) captured by patients directly reporting on their own health outcomes.…

Read more